[1] ALVINA K, JODEIRI FM, MONDAL AK. Long term effects of stress on hippocampal function: Emphasis on early life stress paradigms and potential involvement of neuropeptide Y. J Neurosci Res. 2021;99(1): 57-66.
[2] VIDEBECH P, RAVNKILDE B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry. 2004;161(11): 1957-1966.
[3] TARTT AN, MARIANI MB, HEN R, et al. Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications. Mol Psychiatry. 2022;27(6):2689-2699.
[4] FRIES GR, SALDANA VA, FINNSTEIN J, et al. Molecular pathways of major depressive disorder converge on the synapse. Mol Psychiatry. 2023;28(1):284-297.
[5] DUMAN RS, AGHAJANIAN GK. Synaptic dysfunction in depression: potential therapeutic targets. Science. 2012;338(6103):68-72.
[6] 王舒婷,熊欣欣,刘媛媛.细胞骨架调控大脑皮层神经元迁移机制的研究进展[J].华中科技大学学报(医学版),2022,51(2):281-286.
[7] PAREKH PK, JOHNSON SB, LISTON C. Synaptic Mechanisms Regulating Mood State Transitions in Depression. Annu Rev Neurosci. 2022;45: 581-601.
[8] MCNALLY L, BHAGWAGAR Z, HANNESTAD J. Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr. 2008;13(6): 501-510.
[9] 胡月,曾常茜.小胶质细胞活化与神经炎症相关信号通路的研究进展[J].医学综述,2021,27(20):4005-4010.
[10] SUTTON LP, ORLANDI C, SONG C, et al. Orphan receptor GPR158 controls stress-induced depression. Elife. 2018;7:e33273.
[11] LABOUTE T, ZUCCA S, HOLCOMB M, et al. Orphan receptor GPR158 serves as a metabotropic glycine receptor: mGlyR. Science. 2023; 379(6639):1352-1358.
[12] MLYNIEC K, SIODLAK D, DOBOSZEWSKA U, et al. GPCR oligomerization as a target for antidepressants: Focus on GPR39. Pharmacol Ther. 2021;225:107842.
[13] JIRKOF P, BRATCHER N, MEDINA L, et al. The effect of group size, age and handling frequency on inter-male aggression in CD 1 mice. Sci Rep. 2020;10(1):2253.
[14] LU Q, MOURI A, YANG Y, et al. Chronic unpredictable mild stress-induced behavioral changes are coupled with dopaminergic hyperfunction and serotonergic hypofunction in mouse models of depression. Behav Brain Res. 2019;372:112053.
[15] MARIANI N, CATTANE N, PARIANTE C, et al. Gene expression studies in Depression development and treatment: an overview of the underlying molecular mechanisms and biological processes to identify biomarkers. Transl Psychiatry. 2021;11(1):354.
[16] BROSCH K, STEIN F, SCHMITT S, et al. Reduced hippocampal gray matter volume is a common feature of patients with major depression, bipolar disorder, and schizophrenia spectrum disorders. Mol Psychiatry. 2022;27(10):4234-4243.
[17] RODDY DW, FARRELL C, DOOLIN K, et al. The Hippocampus in Depression: More Than the Sum of Its Parts? Advanced Hippocampal Substructure Segmentation in Depression. Biol Psychiatry. 2019;85(6):487-497.
[18] FRIES GR, SALDANA VA, FINNSTEIN J, et al. Molecular pathways of major depressive disorder converge on the synapse. Mol Psychiatry. 2023;28(1):284-297.
[19] APWEILER M, SALIBA SW, SUN L, et al. Modulation of neuroinflammation and oxidative stress by targeting GPR55 - new approaches in the treatment of psychiatric disorders. Mol Psychiatry. 2024;29(12):3779-3788.
[20] CABRAL-MARQUES O, MOLL G, CATAR R, et al. Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium. Autoimmun Rev. 2023;22(5):103310.
[21] TANAKA S, ISHII K, KASAI K, et al. Neural expression of G protein-coupled receptors GPR3, GPR6, and GPR12 up-regulates cyclic AMP levels and promotes neurite outgrowth.J Biol Chem. 2007;282(14):10506-10515.
[22] WEI Z, XU X, FANG Y, et al. Rab43 GTPase directs postsynaptic trafficking and neuron-specific sorting of G protein-coupled receptors.J Biol Chem. 2021;296:100517.
[23] BRAUNE M, SCHERF N, HEINE C, et al. Involvement of GPR17 in Neuronal Fibre Outgrowth. Int J Mol Sci. 2021;22(21):11683.
[24] A RH, GONG Q, TUO YJ, et al. Syringa oblata Lindl extract alleviated corticosterone-induced depression via the cAMP/PKA-CREB-BDNF pathway. J Ethnopharmacol. 2025;341:119274.
[25] SINHA K, KUMAWAT A, JANG H, et al. Molecular mechanism of regulation of RhoA GTPase by phosphorylation of RhoGDI. Biophys J. 2024;123(1):57-67.
[26] ASLAM M. cAMP/PKA-mediated in vitro angiogenesis: A novel interplay between PKA, RhoA/ROCK, and VEGFR2 signalling. Eur Heart J. 2024; 45(Supplement_1). doi: 10.1093/eurheartj/ehae666.3836
[27] TAN D, ZHANG H, DENG J, et al. RhoA-GTPase Modulates Neurite Outgrowth by Regulating the Expression of Spastin and p60-Katanin. Cells. 2020;9(1):230.
[28] SHIU FH, WONG JC, YAMAMOTO T, et al. Mice lacking full length Adgrb1 (Bai1) exhibit social deficits, increased seizure susceptibility, and altered brain development. Exp Neurol. 2022;351:113994.
[29] ZHU S, HU X, BENNETT S, et al. Molecular Structure, Expression and Role of TAFA4 and its Receptor FPR1 in the Spinal Cord. Front Cell Dev Biol. 2022;10:911414.
[30] WANG S, DELEON C, SUN W, et al. Alternative splicing of latrophilin-3 controls synapse formation. Nature. 2024;626(7997):128-135.
|